Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04898400 · ClinicalTrials.gov registry record · NA

Eosinophils in Human Adipose Tissue

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT04898400: Completed NA study, sponsored by Mayo Clinic.

NCT04898400 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04898400, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The purpose of this study is to better understand the interactions between the innate immune system, in particular eosinophils (EOS), and adipose tissue (AT) in human health and in disease states such as obesity and insulin resistance.

Interventions

  • PROCEDURE endoscopy sleeve gastroplasty

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2021-06-01
Est. Completion 2022-08-26
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04898400

The ClinicalTrials.gov registry entry for NCT04898400 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which endoscopy sleeve gastroplasty is the first listed.

NCT04898400 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04898400 about?

NCT04898400 is a clinical study titled "Eosinophils in Human Adipose Tissue". The purpose of this study is to better understand the interactions between the innate immune system, in particular eosinophils (EOS), and adipose tissue (AT) in human health and in disease states such as obesity and insulin resistance.

What is the current status of trial NCT04898400?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2021-06-01. Estimated completion is 2022-08-26.

What interventions are being tested in trial NCT04898400?

The interventions under investigation include: endoscopy sleeve gastroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT04898400?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.